Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 72 articles:
HTML format
Text format



Single Articles


    December 2018
  1. NIE E, Miao F, Jin X, Wu W, et al
    Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma.
    Oncogene. 2018 Dec 12. pii: 10.1038/s41388-018-0596.
    PubMed     Text format     Abstract available


  2. ZHANG L, Cheng F, Wei Y, Zhang L, et al
    Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells.
    Oncogene. 2018 Dec 12. pii: 10.1038/s41388-018-0626.
    PubMed     Text format     Abstract available


    October 2018
  3. LIU Y, Li F, Yang YT, Xu XD, et al
    IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma.
    Oncogene. 2018 Oct 27. pii: 10.1038/s41388-018-0525.
    PubMed     Text format     Abstract available


  4. ZEPECKI JP, Snyder KM, Moreno MM, Fajardo E, et al
    Regulation of human glioma cell migration, tumor growth, and stemness gene expression using a Lck targeted inhibitor.
    Oncogene. 2018 Oct 23. pii: 10.1038/s41388-018-0546.
    PubMed     Text format     Abstract available


  5. BAKHSHINYAN D, Venugopal C, Adile AA, Garg N, et al
    BMI1 is a therapeutic target in recurrent medulloblastoma.
    Oncogene. 2018 Oct 22. pii: 10.1038/s41388-018-0549.
    PubMed     Text format     Abstract available


  6. LIU X, Bao Y, Meng W, Yang P, et al
    TROY interacts with RKIP to promote glioma development.
    Oncogene. 2018 Oct 18. pii: 10.1038/s41388-018-0503.
    PubMed     Text format     Abstract available


    September 2018
  7. CHEN T, Chen J, Zhu Y, Li Y, et al
    CD163, a novel therapeutic target, regulates the proliferation and stemness of glioma cells via casein kinase 2.
    Oncogene. 2018 Sep 26. pii: 10.1038/s41388-018-0515.
    PubMed     Text format     Abstract available


  8. NEUBAUER HA, Tea MN, Zebol JR, Gliddon BL, et al
    Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastoma.
    Oncogene. 2018 Sep 24. pii: 10.1038/s41388-018-0504.
    PubMed     Text format     Abstract available


    August 2018
  9. TAN Z, Song L, Wu W, Zhou Y, et al
    Correction: TRIM14 promotes chemoresistance in gliomas by activating Wnt/beta-catenin signaling via stabilizing Dvl2.
    Oncogene. 2018 Aug 29. pii: 10.1038/s41388-018-0467.
    PubMed     Text format     Abstract available


  10. WILLEMS E, Dedobbeleer M, Digregorio M, Lombard A, et al
    Aurora A plays a dual role in migration and survival of human glioblastoma cells according to the CXCL12 concentration.
    Oncogene. 2018 Aug 6. pii: 10.1038/s41388-018-0437.
    PubMed     Text format     Abstract available


  11. LIU Z, Wei Y, Zhang L, Yee PP, et al
    Induction of store-operated calcium entry (SOCE) suppresses glioblastoma growth by inhibiting the Hippo pathway transcriptional coactivators YAP/TAZ.
    Oncogene. 2018 Aug 6. pii: 10.1038/s41388-018-0425.
    PubMed     Text format     Abstract available


  12. FENG J, Zhang Y, She X, Sun Y, et al
    Hypermethylated gene ANKDD1A is a candidate tumor suppressor that interacts with FIH1 and decreases HIF1alpha stability to inhibit cell autophagy in the glioblastoma multiforme hypoxia microenvironment.
    Oncogene. 2018 Aug 6. pii: 10.1038/s41388-018-0423.
    PubMed     Text format     Abstract available


    July 2018
  13. KAVERINA NV, Kadagidze ZG, Borovjagin AV, Karseladze AI, et al
    Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma cells and their resistance to adenovirus-mediated oncolysis via upregulation of PUMA and BAX.
    Oncogene. 2018 Jul 10. pii: 10.1038/s41388-018-0395.
    PubMed     Text format     Abstract available


    June 2018
  14. YU OM, Benitez JA, Plouffe SW, Ryback D, et al
    YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity.
    Oncogene. 2018 Jun 11. pii: 10.1038/s41388-018-0301.
    PubMed     Text format     Abstract available


  15. TAN Z, Song L, Wu W, Zhou Y, et al
    TRIM14 promotes chemoresistance in gliomas by activating Wnt/beta-catenin signaling via stabilizing Dvl2.
    Oncogene. 2018 Jun 4. pii: 10.1038/s41388-018-0344.
    PubMed     Text format     Abstract available


    May 2018
  16. BOETTO J, Apra C, Bielle F, Peyre M, et al
    Selective vulnerability of the primitive meningeal layer to prenatal Smo activation for skull base meningothelial meningioma formation.
    Oncogene. 2018 May 22. pii: 10.1038/s41388-018-0328.
    PubMed     Text format     Abstract available


  17. YU M, Li W, Wang Q, Wang Y, et al
    Circadian regulator NR1D2 regulates glioblastoma cell proliferation and motility.
    Oncogene. 2018 May 18. pii: 10.1038/s41388-018-0319.
    PubMed     Text format     Abstract available


  18. ZHOU X, Li G, An S, Li WX, et al
    A new method of identifying glioblastoma subtypes and creation of corresponding animal models.
    Oncogene. 2018 May 17. pii: 10.1038/s41388-018-0305.
    PubMed     Text format     Abstract available


  19. LI N, Zhang Y, Sidlauskas K, Ellis M, et al
    Inhibition of GPR158 by microRNA-449a suppresses neural lineage of glioma stem/progenitor cells and correlates with higher glioma grades.
    Oncogene. 2018 May 3. pii: 10.1038/s41388-018-0277.
    PubMed     Text format     Abstract available


  20. GUO X, Qiu W, Liu Q, Qian M, et al
    Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways.
    Oncogene. 2018 May 1. pii: 10.1038/s41388-018-0261.
    PubMed     Text format     Abstract available


    April 2018
  21. HEUKERS R, Fan TS, de Wit RH, van Senten JR, et al
    The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth.
    Oncogene. 2018 Apr 30. pii: 10.1038/s41388-018-0255.
    PubMed     Text format     Abstract available


  22. BEGUM S, Yiu A, Stebbing J, Castellano L, et al
    Novel tumour suppressive protein encoded by circular RNA, circ-SHPRH, in glioblastomas.
    Oncogene. 2018 Apr 30. pii: 10.1038/s41388-018-0230.
    PubMed     Text format     Abstract available


  23. LU J, Liu L, Zheng M, Li X, et al
    MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function.
    Oncogene. 2018 Apr 17. pii: 10.1038/s41388-018-0249.
    PubMed     Text format     Abstract available


    March 2018
  24. JIN P, Shin SH, Chun YS, Shin HW, et al
    Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-kappaB signaling pathway.
    Oncogene. 2018 Mar 14. pii: 10.1038/s41388-018-0182.
    PubMed     Text format     Abstract available


  25. LIU YY, Chen MB, Cheng L, Zhang ZQ, et al
    microRNA-200a downregulation in human glioma leads to Galphai1 over-expression, Akt activation, and cell proliferation.
    Oncogene. 2018 Mar 9. pii: 10.1038/s41388-018-0184.
    PubMed     Text format     Abstract available


  26. ZHU ZC, Liu JW, Li K, Zheng J, et al
    KPNB1 inhibition disrupts proteostasis and triggers unfolded protein response-mediated apoptosis in glioblastoma cells.
    Oncogene. 2018 Mar 9. pii: 10.1038/s41388-018-0180.
    PubMed     Text format     Abstract available


  27. BOLIN S, Borgenvik A, Persson CU, Sundstrom A, et al
    Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma.
    Oncogene. 2018 Mar 7. pii: 10.1038/s41388-018-0135.
    PubMed     Text format     Abstract available


    February 2018
  28. OYINLADE O, Wei S, Lal B, Laterra J, et al
    Targeting UDP-alpha-D-glucose 6-dehydrogenase inhibits glioblastoma growth and migration.
    Oncogene. 2018 Feb 26. pii: 10.1038/s41388-018-0138.
    PubMed     Text format     Abstract available


  29. CAJA L, Tzavlaki K, Dadras MS, Tan EJ, et al
    Snail regulates BMP and TGFbeta pathways to control the differentiation status of glioma-initiating cells.
    Oncogene. 2018 Feb 16. pii: 10.1038/s41388-018-0136.
    PubMed     Text format     Abstract available


    January 2018
  30. ZHANG M, Huang N, Yang X, Luo J, et al
    A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis.
    Oncogene. 2018 Jan 18. pii: 10.1038/s41388-017-0019.
    PubMed     Text format     Abstract available


  31. SUN L, Yu S, Xu H, Zheng Y, et al
    FHL2 interacts with EGFR to promote glioblastoma growth.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0068.
    PubMed     Text format     Abstract available


  32. LOSKUTOV YV, Griffin CL, Marinak KM, Bobko A, et al
    LPA signaling is regulated through the primary cilium: a novel target in glioblastoma.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0049.
    PubMed     Text format     Abstract available


  33. AN Z, Aksoy O, Zheng T, Fan QW, et al
    Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies.
    Oncogene. 2018 Jan 11. pii: 10.1038/s41388-017-0045.
    PubMed     Text format     Abstract available


    December 2017
  34. BOUSSIOTIS VA, Charest A
    Immunotherapies for malignant glioma.
    Oncogene. 2017 Dec 15. pii: 10.1038/s41388-017-0024.
    PubMed     Text format     Abstract available


    November 2017
  35. ALMIRON BONNIN DA, Havrda MC, Lee MC, Liu H, et al
    Secretion-mediated STAT3 activation promotes self-renewal of glioma stem-like cells during hypoxia.
    Oncogene. 2017 Nov 20. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  36. PROVENZANO L, Ryan Y, Hilton DA, Lyons-Rimmer J, et al
    Cellular prion protein (PrP(C)) in the development of Merlin-deficient tumours.
    Oncogene. 2017;36:6132-6142.
    PubMed     Text format     Abstract available


    October 2017
  37. HOLMES B, Benavides-Serrato A, Freeman RS, Landon KA, et al
    mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  38. OTANI Y, Ichikawa T, Kurozumi K, Inoue S, et al
    Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
    Oncogene. 2017 Oct 23. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  39. VISVANATHAN A, Patil V, Arora A, Hegde AS, et al
    Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance.
    Oncogene. 2017 Oct 9. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  40. CHEN D, Fan Z, Rauh M, Buchfelder M, et al
    ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner.
    Oncogene. 2017;36:5593-5608.
    PubMed     Text format     Abstract available


    September 2017
  41. WANG F, Wang AY, Chesnelong C, Yang Y, et al
    ING5 activity in self-renewal of glioblastoma stem cells via calcium and follicle stimulating hormone pathways.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  42. DEBRUYNE DN, Turchi L, Burel-Vandenbos F, Fareh M, et al
    DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression.
    Oncogene. 2017 Sep 18. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    August 2017
  43. JAIN P, Fierst TM, Han HJ, Smith TE, et al
    CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles.
    Oncogene. 2017 Aug 14. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  44. GUERRERO PA, Tchaicha JH, Chen Z, Morales JE, et al
    Glioblastoma stem cells exploit the alphavbeta8 integrin-TGFbeta1 signaling axis to drive tumor initiation and progression.
    Oncogene. 2017 Aug 7. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    July 2017
  45. YAN D, Kowal J, Akkari L, Schuhmacher AJ, et al
    Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas.
    Oncogene. 2017 Jul 31. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  46. TAYLOR E, Alqadri N, Dodgson L, Mason D, et al
    MRL proteins cooperate with activated Ras in glia to drive distinct oncogenic outcomes.
    Oncogene. 2017;36:4311-4322.
    PubMed     Text format     Abstract available


  47. RODRIGUEZ-BLANCO J, Pednekar L, Penas C, Li B, et al
    Inhibition of WNT signaling attenuates self-renewal of SHH-subgroup medulloblastoma.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  48. ARSLAN AD, Sassano A, Saleiro D, Lisowski P, et al
    Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma.
    Oncogene. 2017 Jul 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    June 2017
  49. YANG JM, Schiapparelli P, Nguyen HN, Igarashi A, et al
    Characterization of PTEN mutations in brain cancer reveals that pten mono-ubiquitination promotes protein stability and nuclear localization.
    Oncogene. 2017;36:3673-3685.
    PubMed     Text format     Abstract available


  50. CASTRO BA, Flanigan P, Jahangiri A, Hoffman D, et al
    Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.
    Oncogene. 2017;36:3749-3759.
    PubMed     Text format     Abstract available


  51. CONDUIT SE, Ramaswamy V, Remke M, Watkins DN, et al
    A compartmentalized phosphoinositide signaling axis at cilia is regulated by INPP5E to maintain cilia and promote Sonic Hedgehog medulloblastoma.
    Oncogene. 2017 Jun 26. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  52. TIAN R, Wang J, Yan H, Wu J, et al
    Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
    Oncogene. 2017 Jun 19. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    May 2017
  53. KESANAKURTI D, Maddirela D, Banasavadi-Siddegowda YK, Lai TH, et al
    A novel interaction of PAK4 with PPARgamma to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma.
    Oncogene. 2017 May 22. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  54. ZHU C, Chrifi I, Mustafa D, van der Weiden M, et al
    CECR1-mediated cross talk between macrophages and vascular mural cells promotes neovascularization in malignant glioma.
    Oncogene. 2017 May 22. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  55. ZENG AL, Yan W, Liu YW, Wang Z, et al
    Tumour exosomes from cells harbouring PTPRZ1-MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  56. KAWAUCHI D, Ogg RJ, Liu L, Shih DJH, et al
    Novel MYC-driven medulloblastoma models from multiple embryonic cerebellar cells.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  57. WALD JH, Hatakeyama J, Printsev I, Cuevas A, et al
    Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination.
    Oncogene. 2017 May 8. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  58. RAJA E, Komuro A, Tanabe R, Sakai S, et al
    Bone morphogenetic protein signaling mediated by ALK-2 and DLX2 regulates apoptosis in glioma-initiating cells.
    Oncogene. 2017 May 1. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  59. LIU YS, Lin HY, Lai SW, Huang CY, et al
    MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma.
    Oncogene. 2017 May 1. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    April 2017
  60. SCHROCK MS, Batar B, Lee J, Druck T, et al
    Wwox-Brca1 interaction: role in DNA repair pathway choice.
    Oncogene. 2017;36:2215-2227.
    PubMed     Text format     Abstract available


  61. NANDHU MS, Kwiatkowska A, Bhaskaran V, Hayes J, et al
    Tumor-derived fibulin-3 activates pro-invasive NF-kappaB signaling in glioblastoma cells and their microenvironment.
    Oncogene. 2017 Apr 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  62. HU PS, Xia QS, Wu F, Li DK, et al
    NSPc1 promotes cancer stem cell self-renewal by repressing the synthesis of all-trans retinoic acid via targeting RDH16 in malignant glioma.
    Oncogene. 2017 Apr 10. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  63. DEGUCHI S, Katsushima K, Hatanaka A, Shinjo K, et al
    Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  64. QI Q, Kang SS, Zhang S, Pham C, et al
    Co-amplification of phosphoinositide 3-kinase enhancer A and cyclin-dependent kinase 4 triggers glioblastoma progression.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  65. SHIN CH, Robinson JP, Sonnen JA, Welker AE, et al
    HBEGF promotes gliomagenesis in the context of Ink4a/Arf and Pten loss.
    Oncogene. 2017 Apr 3. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    February 2017
  66. NATSUME A, Kato T, Kinjo S, Enomoto A, et al
    Girdin maintains the stemness of glioblastoma stem cells.
    Oncogene. 2017 Feb 20. doi: 10.1038/onc.2017.
    PubMed     Text format    


  67. CHEN R, Duan J, Li L, Ma Q, et al
    mTOR promotes pituitary tumor development through activation of PTTG1.
    Oncogene. 2017;36:979-988.
    PubMed     Text format     Abstract available


  68. MASILAMANI AP, Ferrarese R, Kling E, Thudi NK, et al
    KLF6 depletion promotes NF-kappaB signaling in glioblastoma.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    December 2016
  69. VOLPIN F, Casaos J, Sesen J, Mangraviti A, et al
    Use of an anti-viral drug, Ribavirin, as an anti-glioblastoma therapeutic.
    Oncogene. 2016 Dec 12. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    November 2016
  70. SAREDDY GR, Viswanadhapalli S, Surapaneni P, Suzuki T, et al
    Novel KDM1A inhibitors induce differentiation and apoptosis of glioma stem cells via unfolded protein response pathway.
    Oncogene. 2016 Nov 28. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    October 2016
  71. GARG N, Bakhshinyan D, Venugopal C, Mahendram S, et al
    CD133+ brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence.
    Oncogene. 2016 Oct 24. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    September 2016
  72. TALAMILLO A, Grande L, Ruiz-Ontanon P, Velasquez C, et al
    ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA.
    Oncogene. 2016 Sep 19. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: